ABMT OTC
Advanced BioMedical Technologies Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +25.0%
1Y: +400.0%
3Y: -98.8%
5Y: -99.6%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$735K
+13.1% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$735K
+18.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$32K
+80.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$953K | -$949K | -$672K | -$729K | -$515K |
| Depreciation & Amort. | $16K | $21K | $60K | $41K | $19K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $38K | $157K | $1M | -$201K | -$267K |
| Other Non-Cash Items | $67K | $28K | $72K | $44K | $29K |
| Operating Cash Flow | -$832K | -$743K | $647K | -$846K | -$735K |
| — Investing Activities — | |||||
| Capital Expenditures | -$64K | -$19K | -$31K | -$52K | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$64K | -$19K | -$31K | -$52K | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | -$44K | $756K | $711K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $896K | $760K | -$384K | -$30K | -$7K |
| Financing Cash Flow | $896K | $760K | -$428K | $726K | $704K |
| Net Change in Cash | -$603 | -$1K | $196K | -$165K | -$32K |
| Cash End of Period | $7K | $6K | $202K | $37K | $5K |
| Free Cash Flow | -$897K | -$761K | $616K | -$897K | -$735K |